BioNano Genomics Inc (NASDAQ:BNGO)’s stock price traded up 24.7% on Tuesday . The stock traded as high as $1.07 and last traded at $1.06, 8,475,500 shares changed hands during trading. An increase of 515% from the average session volume of 1,377,637 shares. The stock had previously closed at $0.85.
Several analysts have recently weighed in on the stock. Maxim Group restated a “buy” rating and set a $3.00 price objective on shares of BioNano Genomics in a research report on Friday. ValuEngine upgraded shares of BioNano Genomics from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Finally, Zacks Investment Research downgraded shares of BioNano Genomics from a “hold” rating to a “sell” rating in a research report on Monday, September 23rd.
The firm has a market cap of $23.31 million, a PE ratio of -0.41 and a beta of 1.06. The company has a debt-to-equity ratio of 3.13, a quick ratio of 2.05 and a current ratio of 2.40. The firm’s 50-day moving average price is $0.93 and its two-hundred day moving average price is $2.10.
BioNano Genomics Company Profile (NASDAQ:BNGO)
Bionano Genomics, Inc operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics.
Featured Story: Short Selling
Receive News & Ratings for BioNano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.